- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02189018
Activity To Improve Outcomes in Peripheral Arterial Disease (ACTION)
Study Overview
Status
Conditions
Detailed Description
This pilot study seeks to gather data on different exercise interventions in PAD. Collectively, the proposed studies will gather data on the role of novel exercise interventions in those with PAD who are receiving conservative treatment as well as those who have undergone an endovascular intervention for lower extremity arterial disease.
We hypothesize that patients who undergo an exercise intervention will: A) show improved lower extremity perfusion and B) improve their functional ability, compared to a standard care control group over 6 months of follow-up. We further hypothesize that these improvements are mediated through angiogenesis and increased perfusion of the lower limb, as well as improvements in muscle strength, mass, and function.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- Baltimore VAMC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 21-90 years
- Ankle brachial index < 0.9
Exclusion Criteria:
- Cancer under active treatment, except prostate, skin, and hematologic cancers
- Planned for open lower extremity bypass surgery
- Body mass index >45
- Lower extremity gangrene
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control
Ad lib activity at home
|
Ad lib activity at home
|
Experimental: Active Exercise
Active exercise on treadmill
|
Active exercise on a treadmill
|
Experimental: Neuromuscular electrical stimulation
|
Neuromuscular electrical stimulation
|
Experimental: Weight loss and active exercise
Weight loss plus active exercise on treadmill
|
Weight loss and active exercise on a treadmill
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lower extremity perfusion
Time Frame: 6 months
|
Ankle brachial index and ultrasound quantification of muscle perfusion
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional capacity
Time Frame: 6 months
|
Treadmill exercise testing
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Brajesh K Lal, MD, Baltimore VAMC, University of Maryland School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HP-00059151
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Occlusive Disease
-
CID S.p.A.Meditrial Europe Ltd.Not yet recruitingPeripheral Arterial Occlusive Disease | Peripheral Artery DiseaseItaly
-
University of NebraskaNot yet recruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
Western Vascular Institute, IrelandRecruitingPeripheral Arterial Occlusive DiseaseIreland
-
Jena University HospitalAngioDroid s.r.l., Bologna (Italy)CompletedPeripheral Arterial Occlusive DiseaseGermany
-
Seoul National University HospitalAstellas Pharma Korea, Inc.CompletedPeripheral Arterial Occlusive DiseaseKorea, Republic of
-
Heidelberg UniversityTerminatedPeripheral Arterial Occlusive DiseaseGermany
-
Johann Wolfgang Goethe University HospitalSuspendedPeripheral Arterial Occlusive DiseaseGermany
-
University Heart Center Freiburg - Bad KrozingenJohann Wolfgang Goethe University HospitalCompletedPeripheral Arterial Occlusive DiseaseGermany
-
St. Antonius HospitalUMC Utrecht; Albert Schweitzer Hospital; Amphia HospitalUnknownAtherosclerosis | Peripheral Arterial Occlusive DiseaseNetherlands
-
Marissa JarosinskiRecruitingPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery DiseaseUnited States
Clinical Trials on Ad lib activity at home
-
Indiana UniversityCompletedPostoperative Feeding Following PyloromyotomyUnited States
-
Children's Mercy Hospital Kansas CityCompleted
-
Duke UniversityNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); Food and Drug Administration (FDA)TerminatedCigarette Smoking | Nicotine WithdrawalUnited States
-
Institut Cancerologie de l'OuestNot yet recruiting
-
University of OklahomaNational Institute on Drug Abuse (NIDA); Oklahoma State UniversityRecruitingNicotine Dependence | Cigarette Smoking | Nicotine WithdrawalUnited States
-
Children's Mercy Hospital Kansas CityCompletedHeart Failure | Pulmonary Hypertension | Single VentricleUnited States
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingPhysical Activity | Lyme Borreliosis | Lyme Borreliosis, Nervous SystemFrance
-
Centre Hospitalier Universitaire de Saint EtienneCompletedPhysical Activity | FibromyalgiaFrance
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingPhysical Activity | FibromyalgiaFrance